Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim J Peters

Showing results (181-190 of 225) with videos related to

Pageof 23
Sort By:
BMC Musculoskeletal Disorders|December 16, 2023
The STAR care pathway for patients with chronic pain after total knee replacement: four-year follow-up of a randomised controlled trialWendy Bertram, Vikki Wylde, Nick Howells, et al.
BJU International|July 15, 2016
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of lifeAthene Lane, Chris Metcalfe, Grace J Young, et al.
Journal of Medical Internet Research|November 13, 2019
Investigating Software Requirements for Systems Supporting Task-Shifted Interventions: Usability StudyPepijn Van de Ven, Ricardo Araya, Maria Clara P de Paula Couto, et al.
The Lancet. Oncology|August 29, 2014
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trialJ Athene Lane, Jenny L Donovan, Michael Davis, et al.
Health Technology Assessment (Winchester, England)|November 24, 2018
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCTDavid Kessler, Alison Burns, Debbie Tallon, et al.
Trials|September 28, 2023
The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trialKaren Morgan, Mei-See Man, Rachael Bloomer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2022
Genetic and structural basis of the human anti-α-galactosyl antibody responseDavid B Langley, Peter Schofield, Damien Nevoltris, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 23, 2013
Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT TrialSandra Hollinghurst, Fran E Carroll, Anna Abel, et al.
Journal of Clinical Epidemiology|June 7, 2019
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort studyJenny L Donovan, Brent Opmeer, Grace J Young, et al.
Trials|July 23, 2013
Psychological advocacy toward healing (PATH): study protocol for a randomized controlled trialGwen Brierley, Roxane Agnew-Davies, Jayne Bailey, et al.
Pageof 23

Showing results (181-190 of 225) with videos related to

Sort By:
Pageof 23
BMC Musculoskeletal Disorders|December 16, 2023
The STAR care pathway for patients with chronic pain after total knee replacement: four-year follow-up of a randomised controlled trialWendy Bertram, Vikki Wylde, Nick Howells, et al.
BJU International|July 15, 2016
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of lifeAthene Lane, Chris Metcalfe, Grace J Young, et al.
Journal of Medical Internet Research|November 13, 2019
Investigating Software Requirements for Systems Supporting Task-Shifted Interventions: Usability StudyPepijn Van de Ven, Ricardo Araya, Maria Clara P de Paula Couto, et al.
The Lancet. Oncology|August 29, 2014
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trialJ Athene Lane, Jenny L Donovan, Michael Davis, et al.
Health Technology Assessment (Winchester, England)|November 24, 2018
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCTDavid Kessler, Alison Burns, Debbie Tallon, et al.
Trials|September 28, 2023
The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trialKaren Morgan, Mei-See Man, Rachael Bloomer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2022
Genetic and structural basis of the human anti-α-galactosyl antibody responseDavid B Langley, Peter Schofield, Damien Nevoltris, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 23, 2013
Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT TrialSandra Hollinghurst, Fran E Carroll, Anna Abel, et al.
Journal of Clinical Epidemiology|June 7, 2019
Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort studyJenny L Donovan, Brent Opmeer, Grace J Young, et al.
Trials|July 23, 2013
Psychological advocacy toward healing (PATH): study protocol for a randomized controlled trialGwen Brierley, Roxane Agnew-Davies, Jayne Bailey, et al.
Pageof 23